SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS

Overview of attention for article published in Blood, June 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 55,359 followers.

SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in #MDS https://t.co/p1b40mCjFZ https://t.co/0KoARh8rV1

New article: SETD2 deficiency predicts poor prognosis in MDS and accelerated MDS-associated leukemogenesis via S100a9. https://t.co/gxO8eEuz1M #MDS #mdssm #hematology

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.